Week of March 4, 2024

MMWR Weekly Briefing

コンテンツは U.S.Centers for Disease Control and Prevention(CDC) and CENTERS FOR DISEASE CONTROL によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャストコンテンツは、U.S.Centers for Disease Control and Prevention(CDC) and CENTERS FOR DISEASE CONTROL またはそのポッドキャストプラットフォームパートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。

7M ago 6:14

MP3•エピソードのホーム

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on September 19, 2024 16:26 (16d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

This episode discusses four MMWR reports. First, a new CDC study shows that nirsevimab, an antibody, protects babies against RSV hospitalization. Second, unsupervised melatonin ingestion by young children resulted in nearly 11,000 emergency department visits in the U.S. during 2019-2022. Third, a new study finds an increase in the use of blood pressure medicine in people diagnosed with high blood pressure. Finally, out-of-hospital cardiac arrest among adults in Chicago is occurring at younger ages.

182 つのエピソード